Alyeska Investment Group
MAIA icon

Alyeska Investment Group’s MAIA Biotechnology MAIA Stock Holding History

Alyeska Investment Group’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.5M Buy
+2,500,000
New +$4.61M 0.01% 511

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group's MAIA Position: Q1 2026 in Review

Alyeska Investment Group opened a new position in MAIA Biotechnology (MAIA) in Q1 2026: 2,500,000 shares worth $3.5M. The stake represents 0.01% of the portfolio and ranks #511 among its holdings.

33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Alyeska Investment Group held 2,500,000 shares of MAIA Biotechnology worth $3.5M as of Q1 2026.
  • MAIA Biotechnology was a new Alyeska Investment Group position in Q1 2026.
  • MAIA Biotechnology made up 0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #511 holding.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.